🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to compare the efficacy and safety of venetocl...
Status
Completed
Location
Chinese PLA General Hospital
Start Date
2023-03-01
Trial ID
NCT06068621
This randomized phase III trial studies how well imatinib mesylate works in...
Status
Active Not Recruiting
Location
Children's Hospital of Alabama
Start Date
2017-08-08
Trial ID
NCT03007147
Treatments Being Tested
Advances in the biological characterization of AML can now make a proper es...
Status
Unknown
Location
Hospital La Fe
Start Date
2010-12
Trial ID
NCT01296178
Treatments Being Tested
This phase II/III trial studies how well daunorubicin and cytarabine with o...
Status
Active Not Recruiting
Location
University of Arkansas for Medical Sciences
Start Date
2019-03-28
Trial ID
NCT03701308
RATIONALE: Monoclonal antibodies such as rituximab can locate tumor cells a...
Status
Completed
Location
Naval Medical Center - San Diego
Start Date
2002-05
Trial ID
NCT00039130
MRD driven study. Addition of gemtuzumab to conventional chemotherapy to re...
Status
Recruiting
Location
A.O. - SS. Antonio e Biagio e Cesare Arrigo - SC Ematologia
Start Date
2020-09-24
Trial ID
NCT04168502
Treatments Being Tested
Ziftomenib is an investigational drug in development for the treatment of p...
Status
Recruiting
Location
Mayo Clinic - Phoenix
Start Date
2023-07-18
Trial ID
NCT05735184
Treatments Being Tested
Older patients with acute myeloid leukemia (AML) have a small (\< 10%) chan...
Status
Unknown
Location
UZ Antwerpen
Start Date
2014-11-28
Trial ID
NCT02172872
Treatments Being Tested
This phase IB trial studies the feasibility of using a functional laborator...
Status
Completed
Location
OHSU Knight Cancer Institute
Start Date
2016-01-13
Trial ID
NCT02779283
Treatments Being Tested
The study will include newly-diagnosed AML patients, not suffering acute pr...
Status
Unknown
Location
Weill Cornell Medicine
Start Date
2017-07-03
Trial ID
NCT03257241
Treatments Being Tested